Parkinson?s Disease Treatment Market

Parkinson?s disease (PD) is a chronic and progressive disease, considered an idiopathic form, and accounts for roughly 80% of the cases of Parkinsonism?neurological disorders that lead to movement problems. While the exact cause of Parkinson?s disease is unknown, it may include a number of factors such as aging, environmental factors/exposures, and genetic predispositions.
Parkinson?s Disease Treatment Market contains market size and forecasts of Parkinson?s Disease Treatment in Global, including the following market information:
Global Parkinson?s Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Parkinson?s Disease Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Parkinson?s Disease Treatment include Teva, Roche, Prothena, Acorda Therapeutics, Voyager Therapeutics, Impax Pharmaceuticals, UCB, AbbVie and MSD, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Parkinson?s Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Parkinson?s Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Parkinson?s Disease Treatment Market Segment Percentages, by Type, 2021 (%)
Oral
Transdermal
Subcutaneous
Intestinal Infusion
Global Parkinson?s Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Parkinson?s Disease Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Parkinson?s Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Parkinson?s Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Parkinson?s Disease Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Parkinson?s Disease Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva
Roche
Prothena
Acorda Therapeutics
Voyager Therapeutics
Impax Pharmaceuticals
UCB
AbbVie
MSD
Orion Pharmaceuticals
Intec Pharma
NeuroDerm
Adamas Therapeutics
Acadia
Sunovion
GSK